SABCS Session Provides Clinical Implications of New Data and Practical Takeaways
Experts reflected on how clinical decision-making for treating breast cancer may change in light of the latest results shared...
Experts reflected on how clinical decision-making for treating breast cancer may change in light of the latest results shared...
At the San Antonio Breast Cancer Symposium, experts discussed the implications of sexual health, supplements, exercise, and diet for...
In the final three months of 2024, the FDA issued 15 approvals in oncology, including several therapies that are...
A session on molecular degraders at SABCS 2024 highlighted an exciting new frontier for SERDs, PROTACs, LYTACs, and biparatopic...
Researchers at the 2024 San Antonio Breast Cancer Symposium discussed considerations for treating and managing of early-onset breast cancer.
Studies presented at the 2024 SABCS examined ways to predict responses to treatments for HR-positive, HER2-negative breast cancer.
Data from clinical trials presented at SABCS may help patients with DCIS make informed choices between different management...
The Black TNBC Sanctuary is a resource that provides key information and resources specifically for Black patients with TNBC.
Changes to sexual health during breast cancer treatment can impact quality of life and treatment adherence—especially in Black women.
This quarter’s 16 approvals include a first-in-class cell therapeutic, a flurry of new options for EGFR-mutated lung cancer, and...